Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azzalure Injection Volumes for Glabellar Lines
NCT02108158Phase 4Completed
- Sponsor
- Galderma
- Start
- Apr 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of botulinum toxin type A in glabellar lines (2 arms), sponsored by Galderma. Primary endpoint: Assessment of severity of glabellar lines at rest and at maximum frown using the Merz Aesthetic 5-point scale at Month 1. Started Apr 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02108158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108158.